Brief: Infant Bacterial Therapeutics Gets FDA Request For Type B Pre-BLA Meeting
21/09/2026 08:08
BRIEF-Infant Bacterial Therapeutics Gets FDA Request For Type B Pre-BLA Meeting Sept 21 (Reuters) - Infant Bacterial Therapeutics AB IBTb.ST:
FDA GRANTS INFANT BACTERIAL THERAPEUTICS AB’S REQUEST FOR A TYPE B PRE-BLA MEETING
MEETING WILL TAKE PLACE ON OCTOBER 29, 2026, IN WASHINGTON
Source text: ID:nMFN75mGPg
Further company coverage: [IBTb.ST]
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Infant Bacterial Therapeutics AB
See all newsBrief: Infant Bacterial Therapeutics Gets FDA Request For Type B Pre-BLA Meeting
Brief: Infant Bacterial Therapeutics Q2 Operating Loss Widens To SEK 30.1 Mln
Brief: Infant Bacterial Therapeutics CFO Leaves The Company
Brief: Infant Bacterial Announces Phase III IBP-9414 Study Results
Brief: Infant Bacterial Therapeutics Q4 Operating Loss SEK 20.5 Mln